Waksal Harlan 4
4 · Lyra Therapeutics, Inc. · Filed Feb 18, 2022
Insider Transaction Report
Form 4
Waksal Harlan
DirectorExecutive Chair
Transactions
- Award
Stock Option
2022-02-16+520,000→ 520,000 totalExercise: $4.21Exp: 2032-02-15→ Common Stock (520,000 underlying)
Footnotes (1)
- [F1]On February 16, 2022, the Reporting Person was granted an option to purchase 520,000 shares of common stock. The option vests and becomes exercisable as to 173,333 shares underlying the option when the Issuer's market capitalization reaches $250,000,000; (ii) 173,333 shares underlying the option when the Issuer's market capitalization reaches $350,000,000; and (iii) 173,334 shares underlying the option when the Issuer's market capitalization reaches $500,000,000, all subject to the Reporting Person's continued service to the Issuer through each such date.